相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort
Michael Schwarzl et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review
Evelien E. S. van Riet et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms
Enrico Vizzardi et al.
CLINICAL RESEARCH IN CARDIOLOGY (2015)
Angiopoietin-2 and outcome in patients with acute decompensated heart failure
Janine Poess et al.
CLINICAL RESEARCH IN CARDIOLOGY (2015)
Forty-year trends in cardiovascular risk factors in Finland
Katja Borodulin et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2015)
Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis
Christian Ukena et al.
CLINICAL RESEARCH IN CARDIOLOGY (2014)
The Gutenberg Health Study
P. S. Wild et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2012)
Comparison of Midregional Pro-A-Type Natriuretic Peptide and the N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Mortality and Cardiovascular Events
Kornelis J. J. van Hateren et al.
CLINICAL CHEMISTRY (2012)
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea
Ravi V. Shah et al.
EUROPEAN HEART JOURNAL (2012)
GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?
Kai C. Wollert et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity
Andrea Baessler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults The Rancho Bernardo Study
Lori B. Daniels et al.
CIRCULATION (2011)
Biomarkers: optimizing treatment guidance in heart failure
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2011)
Distribution and Categorization of Left Ventricular Measurements in the General Population Results From the Population-Based Gutenberg Heart Study
Philipp S. Wild et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2010)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea Results From the BACH (Biomarkers in Acute Heart Failure) Trial
Alan Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea-Results from the BASEL study
Markus Noveanu et al.
AMERICAN HEART JOURNAL (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Measures of obesity and cardiovascular risk among men and women
Rebecca P. Gelber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
Thomas J. Wang et al.
CIRCULATION (2007)
Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea
Antoni Bayes-Genis et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay
Tibor Kempf et al.
CLINICAL CHEMISTRY (2007)
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study
Lori B. Daniels et al.
AMERICAN HEART JOURNAL (2006)
Recommendations for chamber quantification
Roberto M. Lang et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2006)
Impact of body mass and body composition on circulating levels of natriuretic peptides - Results from the Dallas heart study
SR Das et al.
CIRCULATION (2005)
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome
MH Olsen et al.
HYPERTENSION (2005)
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2005)
Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: A ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy
DG Krauser et al.
AMERICAN HEART JOURNAL (2005)
Impact of obesity on plasma natriuretic peptide levels
TJ Wang et al.
CIRCULATION (2004)
Immunoluminometric assay for the midregion of pro-Atrial natriuretic peptide in human plasma
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2004)
分享论文
